By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
Despite a 194% YTD gain, Adams Asset Advisors trimmed their CLMT stake by 38%, indicating profit-taking and potential concerns about the company's profitability, high debt-to-EBITDA ratio, and exposure to energy cycle and policy risks.
Risk: The 'price discovery' phase once the DOE loan is fully drawn, which could lead to valuation compression if the market realizes the debt-to-EBITDA remains elevated despite the $220M paydown.
Opportunity: The potential for CLMT to hit its 120-150 million gallon SAF target, which could justify the current valuation and potentially lead to further gains.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Adams Asset Advisors sold 1,954,039 shares of Calumet during Q1 2026, with an estimated trade value of approximately $50.3 million based on quarterly average pricing.
Despite the sale, the quarter-end value of Adams' Calumet position actually increased by roughly $12.5 million -- a reflection of CLMT's strong price appreciation during the period.
Adams' remaining stake of 3,202,232 shares was valued at approximately $115.0 million (as of the most recent 13F filing).
Calumet now represents Adams' single largest holding at roughly 12.9% of assets under management (AUM).
According to an SEC filing dated April 27, 2026, Adams Asset Advisors, LLC reduced its holding in Calumet (NASDAQ:CLMT) by 1,954,039 shares during the first quarter of 2026. The estimated value of the shares sold was approximately $50.3 million, based on the average closing price for the quarter. Despite the reduction, the quarter-end value of the Calumet position increased by roughly $12.5 million -- a figure that reflects meaningful price appreciation in CLMT shares during the period.
NYSE:ET: $27.8 million (3.1% of AUM)
As of April 27, 2026, Calumet shares were trading at $30.82, up roughly 194% over the past year, outperforming the S&P 500 by about 164 percentage points.
| Metric | Value | |---|---| | Market capitalization | $2.68 billion | | Revenue (TTM) | $4.14 billion | | Net income (TTM) | ($33.80 million) |
Calumet, Inc. manufactures, formulates, and markets a diversified portfolio of specialty-branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets.
After a nearly 200% run-up in Calumet's share price over the past year, Adams Asset Advisors' decision to trim 1.95 million shares looks a lot like classic profit-taking -- not a loss of faith in the company. Notably, even after the sale, Calumet remains Adams' single largest position, which says a lot about the firm's ongoing conviction.
The business itself has shown real progress. For full-year 2025, Calumet reported revenue of $4.1 billion and adjusted EBITDA with tax attributes of $293.3 million -- roughly 28% higher than the prior year -- while cutting its restricted-group debt load by more than $220 million. Q4 2025 earnings per share came in at ($0.43), which -- although still negative -- beat analyst expectations. The company's Montana Renewables subsidiary also secured a $1.44 billion Department of Energy loan guarantee and is pursuing a sustainable aviation fuel (SAF) expansion it estimates will add 120 to 150 million gallons of annual capacity at relatively modest incremental capital cost.
That said, Calumet remains a money-losing business for now, and energy-related stocks as a category are historically prone to large cyclical swings -- driven by shifts in commodity prices, refining margins, and energy policy -- that can quickly reverse. For investors interested in the specialty chemicals and renewable fuels space, diversified energy ETFs -- such as the Energy Select Sector SPDR Fund (NYSEMKT:XLE) -- offer broader exposure without concentrating in a single name.
Before you buy stock in Calumet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Calumet wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $498,522! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,276,807!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 200% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of April 27, 2026. *
Andy Gould has no position in any of the stocks mentioned. The Motley Fool recommends Occidental Petroleum. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Calumet's aggressive debt reduction and the DOE-backed SAF expansion create a fundamental inflection point that outweighs the short-term noise of institutional profit-taking."
Adams Asset Advisors trimming CLMT after a 200% run is standard portfolio rebalancing, not a signal of fundamental deterioration. With Calumet still comprising 12.9% of their AUM, the firm is clearly maintaining a high-conviction bet on the Montana Renewables (MRL) expansion. The real story here is the de-leveraging—paying down $220 million in debt while securing a $1.44 billion DOE loan guarantee provides a massive moat for their sustainable aviation fuel (SAF) pivot. At a $2.68 billion market cap, the market is pricing in execution risk on the SAF capacity expansion. If they hit the 120-150 million gallon target, the current valuation is likely a floor, not a ceiling.
The company remains unprofitable on a TTM basis, and the reliance on government-backed loan guarantees and tax attributes suggests the business model is currently more dependent on policy subsidies than organic free cash flow.
"Adams' 38% stake cut in CLMT after a 194% run signals profit-taking at highs amid ongoing losses and cyclical risks."
Adams Asset Advisors slashed its CLMT stake by 38% (1.95M shares for $50M in Q1 2026), a hefty trim despite the position's value rising $12.5M on 194% YTD gains to $30.82/share. While still their top holding at 12.9% ($115M) of AUM—ahead of OXY—such profit-taking often precedes pullbacks in cyclicals. CLMT's TTM net loss ($33.8M) on $4.14B revenue highlights persistent unprofitability, with Montana Renewables' SAF expansion (120-150M gal capacity) hinging on a $1.44B DOE loan and subsidies prone to policy reversals. EBITDA rose 28% to $293M and debt fell $220M, but refining margins remain volatile—watch crack spreads.
Counterpoint: Adams' decision to retain the largest position post-trim and CLMT's debt reduction plus DOE-backed renewables growth signal enduring conviction in a cheap (0.65x P/S) turnaround story.
"Adams' partial exit after a 194% run signals profit-taking in a fundamentally unprofitable company dependent on policy tailwinds, not conviction in a turnaround."
Adams' sale looks surgical, not panicked: they trimmed 37.8% of their position while it remained their largest holding post-sale at 12.9% of AUM. The real signal isn't the sale—it's that they kept $115M in CLMT despite a 194% run. What's buried: CLMT is still unprofitable (TTM net income: -$33.8M), trades at a $2.68B market cap on $4.14B revenue, and depends heavily on commodity refining margins and policy-driven SAF subsidies. The $1.44B DOE loan guarantee is real, but it's a *guarantee*, not revenue. Energy stocks are cyclical; we're in a policy-friendly window that could close.
If Montana Renewables' SAF expansion materializes at scale and CLMT reaches sustained profitability by 2027, a 12.9% portfolio weight in a $2.68B cap stock that's still climbing could be the contrarian winner—Adams may be trimming winners to rebalance, not fleeing.
"CLMT’s negative earnings and high cyclicality create a fragile setup, and Adams’ 12.9% AUM concentration means any underperformance could trigger further selling, making the rally vulnerable to a policy/commodity downturn."
Adams trimmed 1.95 million CLMT shares for ~$50.3M in Q1, yet CLMT has surged ~194% Y/Y and remains Adams' single largest position at 12.9% of AUM. The piece frames this as classic profit-taking, but it glosses over material fundamentals: CLMT is still money-losing on a TTM basis, exposed to energy-cycle and policy risk, and its Montana Renewables loan-guarantee remains a conditional catalysts with execution risk. Concentration risk is high for Adams; any adverse turn in the refining/renewables cycle could force further liquidations. Missing is how Adams views macro drivers, alternative exposures, and the durability of CLMT’s EBITDA gains amid cyclicality.
The sale could simply be rebalancing or liquidity needs, not a negative view on CLMT; a continued rally could persist even if fundamentals wobble, reducing the relevance of this trim as a signal.
"Adams' trim is likely a forced liquidity move to manage concentration risk in a low-float stock rather than a purely fundamental rebalancing."
Claude, you’re missing the liquidity trap. Adams isn't just rebalancing; they are likely managing concentration risk in a low-float, volatile micro-cap. With a $2.68B market cap, a 12.9% position is effectively illiquid in a sell-off. The real risk isn't the policy window closing—it's the 'price discovery' phase once the DOE loan is fully drawn. If the market realizes the debt-to-EBITDA remains elevated despite the $220M paydown, this valuation will compress regardless of SAF volume.
"CLMT's negative FCF persists due to heavy MRL capex, requiring sustained high crack spreads for viability."
Gemini, your debt-to-EBITDA warning post-DOE draw is spot-on, but nobody flags the kicker: CLMT's TTM levered free cash flow remains deeply negative (-$200M+ est. after $500M+ capex), even with EBITDA at $293M. Adams' trim isn't just liquidity—it's prescient on capex burn outpacing subsidies until SAF volumes hit in 2027. Crack spreads must hold $25+/bbl or valuation craters.
"Capex burn is only a death knell if SAF ramp slips; the real risk is timing misalignment between capex draw and revenue inflection, not the absolute FCF level today."
Grok nails the capex trap, but we're conflating two separate risks. TTM FCF being negative isn't predictive if capex is front-loaded for MRL expansion—the real test is whether SAF volumes justify the $1.44B DOE draw timeline. Gemini's debt-to-EBITDA concern post-draw is valid, but the math hinges on *when* revenues materialize. If 2027 SAF ramp delivers, today's capex burn looks prescient, not reckless. The crack spread floor at $25/bbl is the actual tripwire nobody quantified.
"Policy-financing risk from SAF subsidies and DOE loan draw timing could cap upside and compress CLMT's valuation even if SAF volumes materialize."
Reply to Grok: Crack spreads aren’t the only tripwire. The bigger risk is the policy-financing dial: the SAF subsidies and the timing/availability of the $1.44B DOE loan draw. If subsidies roll back or financing is slower-than-expected, Montana Renewables’ capex burn may outpace any EBITDA gains, leaving DSCR tight and equity value more vulnerable than a crude-spread-only framework suggests. That would compress CLMT’s multiple even if volumes hit the 120-150M gal target.
Despite a 194% YTD gain, Adams Asset Advisors trimmed their CLMT stake by 38%, indicating profit-taking and potential concerns about the company's profitability, high debt-to-EBITDA ratio, and exposure to energy cycle and policy risks.
The potential for CLMT to hit its 120-150 million gallon SAF target, which could justify the current valuation and potentially lead to further gains.
The 'price discovery' phase once the DOE loan is fully drawn, which could lead to valuation compression if the market realizes the debt-to-EBITDA remains elevated despite the $220M paydown.